Time-dependent systolic and diastolic function in mice overexpressing calcineurin.

Echocardiograms have been assessed only at 56 days in mice overexpressing calcineurin (CN mice). Age-dependent echocardiographic changes were evaluated because the development of sudden death is time dependent. Because cyclosporin A (CsA) reverses hypertrophy in CN mice, its effects on the time course of the development of sudden death and cardiac dysfunction were assessed. In wild-type (WT) mice, the left ventricular (LV) internal end-diastolic dimension (LVIDd) increased and the LV mass index (LVMI) decreased with age. In CN mice, two distinct phases of pathophysiology were found. After 14 days, in CN mice, the LVIDd and LVMI were significantly increased, but sudden death had not occurred. After 28 days, in CN mice, relative dilation of the left ventricle occurred, whereas the LVMI decreased. Sudden death developed during progressive dilation associated with systolic and diastolic dysfunction. CsA treatment reversed hypertrophy in CN mice but did not reverse systolic and diastolic dysfunction and exaggerated sudden death. Sudden cardiac death was associated with systolic and diastolic dysfunction but was not related to isolated cardiac hypertrophy in CN mice.

[1]  D. Severson,et al.  Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[2]  Y. Takeishi,et al.  Cardiac hypertrophy and failure: lessons learned from genetically engineered mice. , 2001, Acta physiologica Scandinavica.

[3]  D. Kass,et al.  Minimal force‐frequency modulation of inotropy and relaxation of in situ murine heart , 2001, The Journal of physiology.

[4]  D. Burkhoff,et al.  Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. , 2001, American journal of physiology. Heart and circulatory physiology.

[5]  J. Molkentin,et al.  Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. , 2001, Journal of molecular and cellular cardiology.

[6]  Mark A Sussman,et al.  Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. , 2000, Journal of molecular and cellular cardiology.

[7]  A Haase,et al.  Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[8]  Y. Zou,et al.  Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. , 1999, Circulation.

[9]  O. Carretero,et al.  Echocardiographic assessment of cardiac function in conscious and anesthetized mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[10]  E. Olson,et al.  Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. , 1999, Circulation research.

[11]  M. Entman,et al.  Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. , 1998, The Journal of clinical investigation.

[12]  Mark A Sussman,et al.  Prevention of cardiac hypertrophy in mice by calcineurin inhibition. , 1998, Science.

[13]  J. Lorenz,et al.  End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[14]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[15]  G. Fishman,et al.  The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. , 1998, Cardiovascular research.

[16]  W. Colucci Molecular and cellular mechanisms of myocardial failure. , 1997, The American journal of cardiology.

[17]  M. Entman,et al.  Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. , 1996, The American journal of physiology.

[18]  R. Walsh,et al.  In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.

[19]  W. Little,et al.  Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. , 1994, Circulation.

[20]  H. E. Keurs,et al.  Excitation-contraction coupling in rat heart: influence of cyclosporin A. , 1993, Cardiovascular research.

[21]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[22]  E. Starling,et al.  The regulation of the heart beat , 1914, The Journal of physiology.